The Gastrointestinal Cancer Channel is supported with funding from Gilead Sciences (Silver) and Revolution Medicines (Silver).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ESMO 2022 | Role of perioperative therapy in colon cancer
Alvaro Arjona-Sanchez, MD, Reina Sofia University Hospital, Córdoba, Spain, outlines the role of perioperative therapy in colorectal cancer, highlighting the role of HIPEC and mitomycin C. This interview took place at the European Society for Medical Oncology (ESMO) 2022 Congress in Paris, France.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
